Sort by
Refine Your Search
-
for yield management through ensuring London Business School remains engaged with applicants from the point of enquiry until the point of entry to the programme on their first day, and through management
-
are delighted to be recruiting for a data literate and passionate Data Lead, Aware to Admit to join Technology on a fixed-term basis. The Aware to Admit Programme is a cross-functional initiative aimed
-
Scheme and support the administration of various financial awards including QM Prizes, Scholarships, the Expedition Fund, the Cambridge Long Vacation Scheme and the US Loans Programme. The post will
-
locally-employed laboratory personnel, ensuring all laboratory activities related to the LSHTM-COMAHS programme and ancillary and future studies are performed in strict accordance to Good Clinical
-
female Professors in both the Centre for Programming Languages and Systems and the Centre for Intelligent Systems. We strongly welcome applications from women and those from under-represented backgrounds
-
, though complementary and following the Institute strategic plan, also have Centre-specific objectives and requirements. The Centre for Cancer Screening, Prevention and Early Diagnosis (CCSPED) forms part
-
the University, in accordance with the Immigration, Asylum and Nationality Act 2006. Full-Time, Permanent Applications are invited for the post of Sports Grounds Manager in the Active Lifestyle and Sport Team
-
supervised by Dr. Damien Tully and applicants are encouraged to contact Dr. Tully (Damien.Tully@lshtm.ac.uk ) for an informal discussion prior to submitting a formal application. The post-holder will have a
-
governance activities for LSHTM’s clinical trials. Lead on the strategic development and deployment of robust electronic research data collection solutions, including oversight of application programming. Lead
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing